Gler of the University of Virginia
04, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
Wild concept, apparently
We also rely on micronutrient testing to get a forward-looking analysis of vitamin and mineral deficiencies something thats especially important for people using GLP-1s, where eating less can quietly mean absorbing less. One of the biggest misconceptions that Berjis hears when it comes to using GLP-1s
Some notable options include PlushCare, which offers personalized weight loss programs with virtual consultations, and Noom Med, which combines GLP-1 medications with behavioral coaching
Common side effects include nausea, diarrhea, constipation, and vomiting